Spatial genomics suggested that the molecular portrait of androgen receptor (AR)-expressing breast cancer cells in tumor microenvironment corresponds to better overall patient survival, clinically confirming AR’s role as a tumor suppressor.
[Proceedings of The National Academy of Sciences of The United States of America]